Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.04
THC's Cash to Debt is ranked higher than
51% of the 245 Companies
in the Global Medical Care industry.

( Industry Median: 0.24 vs. THC: 0.04 )
THC' s 10-Year Cash to Debt Range
Min: 0   Max: 0.35
Current: 0.04

0
0.35
Equity to Asset 0.04
THC's Equity to Asset is ranked lower than
52% of the 242 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. THC: 0.04 )
THC' s 10-Year Equity to Asset Range
Min: 0   Max: 0.45
Current: 0.04

0
0.45
Interest Coverage 1.40
THC's Interest Coverage is ranked higher than
53% of the 163 Companies
in the Global Medical Care industry.

( Industry Median: 5.75 vs. THC: 1.40 )
THC' s 10-Year Interest Coverage Range
Min: 0.62   Max: 6.4
Current: 1.4

0.62
6.4
F-Score: 4
Z-Score: 0.90
M-Score: -1.74
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 5.97
THC's Operating margin (%) is ranked higher than
68% of the 247 Companies
in the Global Medical Care industry.

( Industry Median: 9.14 vs. THC: 5.97 )
THC' s 10-Year Operating margin (%) Range
Min: -14.26   Max: 15.05
Current: 5.97

-14.26
15.05
Net-margin (%) -1.21
THC's Net-margin (%) is ranked higher than
59% of the 247 Companies
in the Global Medical Care industry.

( Industry Median: 4.82 vs. THC: -1.21 )
THC' s 10-Year Net-margin (%) Range
Min: -32   Max: 12.42
Current: -1.21

-32
12.42
ROE (%) -17.75
THC's ROE (%) is ranked higher than
50% of the 239 Companies
in the Global Medical Care industry.

( Industry Median: 8.44 vs. THC: -17.75 )
THC' s 10-Year ROE (%) Range
Min: -304.17   Max: 64.72
Current: -17.75

-304.17
64.72
ROA (%) -0.83
THC's ROA (%) is ranked higher than
58% of the 248 Companies
in the Global Medical Care industry.

( Industry Median: 3.59 vs. THC: -0.83 )
THC' s 10-Year ROA (%) Range
Min: -27.83   Max: 13.45
Current: -0.83

-27.83
13.45
ROC (Joel Greenblatt) (%) 7.79
THC's ROC (Joel Greenblatt) (%) is ranked higher than
64% of the 246 Companies
in the Global Medical Care industry.

( Industry Median: 15.98 vs. THC: 7.79 )
THC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -20.93   Max: 28.47
Current: 7.79

-20.93
28.47
Revenue Growth (%) 18.50
THC's Revenue Growth (%) is ranked higher than
94% of the 203 Companies
in the Global Medical Care industry.

( Industry Median: 7.00 vs. THC: 18.50 )
THC' s 10-Year Revenue Growth (%) Range
Min: -13.7   Max: 18.5
Current: 18.5

-13.7
18.5
EBITDA Growth (%) 5.70
THC's EBITDA Growth (%) is ranked higher than
73% of the 172 Companies
in the Global Medical Care industry.

( Industry Median: 6.70 vs. THC: 5.70 )
THC' s 10-Year EBITDA Growth (%) Range
Min: -47.2   Max: 31.5
Current: 5.7

-47.2
31.5
» THC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

THC Guru Trades in Q3 2013

David Tepper 210,000 sh (New)
Ray Dalio 16,473 sh (New)
John Griffin 3,085,000 sh (+45.52%)
Larry Robbins 9,999,339 sh (+1.63%)
Vanguard Health Care Fund 1,400,000 sh (unchged)
Paul Tudor Jones Sold Out
Steven Cohen 208,734 sh (-5.42%)
Jeremy Grantham 20,038 sh (-13.29%)
Jim Simons 247,775 sh (-41.37%)
» More
Q4 2013

THC Guru Trades in Q4 2013

Paul Tudor Jones 5,600 sh (New)
Larry Robbins 13,812,831 sh (+38.14%)
Ray Dalio 21,729 sh (+31.91%)
Vanguard Health Care Fund 1,400,000 sh (unchged)
John Griffin Sold Out
David Tepper Sold Out
Jeremy Grantham 11,743 sh (-41.4%)
Jim Simons 63,075 sh (-74.54%)
Steven Cohen 13,913 sh (-93.33%)
» More
Q1 2014

THC Guru Trades in Q1 2014

Louis Moore Bacon 8,988 sh (New)
Manning & Napier Advisors, Inc 220,380 sh (New)
Mario Gabelli 15,000 sh (New)
Steven Cohen 21,789 sh (+56.61%)
Ray Dalio 33,400 sh (+53.71%)
Vanguard Health Care Fund 1,400,000 sh (unchged)
Larry Robbins 13,812,831 sh (unchged)
Jim Simons Sold Out
Jeremy Grantham Sold Out
Paul Tudor Jones Sold Out
» More
Q2 2014

THC Guru Trades in Q2 2014

George Soros 22,150 sh (New)
Louis Moore Bacon 154,841 sh (+1622.75%)
Mario Gabelli 15,000 sh (unchged)
Vanguard Health Care Fund 1,400,000 sh (unchged)
Manning & Napier Advisors, Inc 220,380 sh (unchged)
Larry Robbins 13,812,831 sh (unchged)
Ray Dalio 14,725 sh (-55.91%)
» More
» Details

Insider Trades

Latest Guru Trades with THC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Tenet Healthcare Corp

Gabelli and Robbins Highlight Guru Buys of the Week
The following information is a highlight of the real-time guru activity we saw this week. To view more information on these gurus, check out their guru portfolios. The “Real Time Picks” reports the stock purchases and sells that Gurus have made within the prior two weeks. If a Guru makes a purchase or sell of a company in which they own a greater-than 5% stake, SEC regulations require them to report their transaction within two days. This week we saw notable increases in Real Time activity from Mario Gabelli and Larry Robbins. Read more...
Larry Robbins Ups Holdings in Health Care Company
Yesterday GuruFocus Real Time Picks reported two guru buys coming from Larry Robbins into the company Tenet Healthcare (THC). The guru made these two buys on two different days over the past week. Read more...
Billionaires Active on PXD, THC, SNI
Here’s the third quarter update for three companies listed among the S&P500’s "biggest losers," including Pioneer Natural Resources Company (PXD), Scripps Networks Interactive Inc. (SNI) and Tenet Healthcare Corp. (THC). Numerous billionaires hold these stocks and there is active insider trading for all three. Read more...

Ratios

vs
industry
vs
history
P/B 8.20
THC's P/B is ranked lower than
64% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 2.96 vs. THC: 8.20 )
THC' s 10-Year P/B Range
Min: 1.09   Max: 101.5
Current: 8.2

1.09
101.5
P/S 0.40
THC's P/S is ranked higher than
92% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 1.55 vs. THC: 0.40 )
THC' s 10-Year P/S Range
Min: 0.05   Max: 0.85
Current: 0.4

0.05
0.85
EV-to-EBIT 24.82
THC's EV-to-EBIT is ranked higher than
75% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 26.73 vs. THC: 24.82 )
THC' s 10-Year EV-to-EBIT Range
Min: 9.4   Max: 31.8
Current: 24.82

9.4
31.8
Shiller P/E 33.00
THC's Shiller P/E is ranked higher than
79% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. THC: 33.00 )
THC' s 10-Year Shiller P/E Range
Min: 15.34   Max: 1038
Current: 33

15.34
1038
Current Ratio 1.24
THC's Current Ratio is ranked higher than
69% of the 170 Companies
in the Global Medical Care industry.

( Industry Median: 1.55 vs. THC: 1.24 )
THC' s 10-Year Current Ratio Range
Min: 0.9   Max: 2.38
Current: 1.24

0.9
2.38
Quick Ratio 1.17
THC's Quick Ratio is ranked higher than
69% of the 170 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. THC: 1.17 )
THC' s 10-Year Quick Ratio Range
Min: 0.85   Max: 2.29
Current: 1.17

0.85
2.29

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 4.07
THC's Price/Median PS Value is ranked lower than
65% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 1.20 vs. THC: 4.07 )
THC' s 10-Year Price/Median PS Value Range
Min: 0.16   Max: 12.42
Current: 4.07

0.16
12.42
Earnings Yield (Greenblatt) 4.00
THC's Earnings Yield (Greenblatt) is ranked higher than
59% of the 235 Companies
in the Global Medical Care industry.

( Industry Median: 5.20 vs. THC: 4.00 )
THC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.1   Max: 10.6
Current: 4

3.1
10.6
Forward Rate of Return (Yacktman) 8.46
THC's Forward Rate of Return (Yacktman) is ranked higher than
74% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 11.21 vs. THC: 8.46 )
THC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -108   Max: 9.6
Current: 8.46

-108
9.6

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:THC1.Germany
Tenet Healthcare Corporation, a Nevada corporation was incorporated in 1975. The Company is an investor-owned health care services company whose subsidiaries and affiliates mainly operate acute care hospitals, ambulatory surgery centers, diagnostic imaging centers and related health care facilities. Its core business is focused on providing acute care treatment, including inpatient care, intensive care, cardiac care, radiology services and emergency medical treatment. Its subsidiaries operated 49 hospitals, including three academic medical centers and a critical access hospital, with a combined total of 13,216 licensed beds, serving mainly urban and suburban communities in 10 states. Each of its general hospitals offers acute care services, operating and recovery rooms, radiology services, respiratory therapy services, clinical laboratories and pharmacies; in addition, most offer intensive care, critical care and/or coronary care units, physical therapy, and orthopedic, oncology and outpatient services. A number of its hospitals also offer tertiary care services such as open-heart surgery, neonatal intensive care and neuroscience. Two of its hospitals — St. Louis University Hospital and Hahnemann University Hospital — offer quaternary care in areas such as heart, liver, kidney and bone marrow transplants. St. Christopher's Hospital for Children provides tertiary and quaternary pediatric services, including bone marrow and kidney transplants, as well as burn services. Sierra Medical Center, Good Samaritan Medical Center and North Shore Medical Center offer gamma-knife brain surgery; and Brookwood Medical Center, North Shore Medical Center, Saint Francis Hospital and St. Louis University Hospital offers cyberknife radiation therapy for tumors and lesions nearly anywhere in the body, including in the brain, lung, neck and spine that may have been previously considered inoperable or inaccessible by traditional radiation therapy. In addition, its hospitals will continue their efforts to deliver and develop those outpatient services that can be provided on a quality, cost-effective basis. The Company is facing competition from specialty hospitals (some of which are physician-owned) and unaffiliated freestanding outpatient centers for market share in high margin services and for quality physicians and personnel. Furthermore, some of the hospitals that compete with its hospitals are owned by government agencies or not-for-profit organizations. The Company is subject to a number of laws and regulations affecting its use of, and purchase and sale of, real property. Among these are California's seismic standards, the Americans with Disabilities Act, and various environmental laws and regulations.
» More Articles for THC

Headlines

Articles On GuruFocus.com
ObamaCare A Boon For Hostpitals Aug 19 2014 
A Far-Larger Hospital and a Far-Larger Stock Position Jan 02 2014 
Gabelli and Robbins Highlight Guru Buys of the Week Dec 27 2013 
Larry Robbins Ups Holdings in Health Care Company Dec 24 2013 
Robbins, Cohen and Karr Highlight the Guru Real Time Picks of the Week Dec 20 2013 
Glenview Capital - Larry Robbins in Real Time and Review Nov 15 2013 
Blue Ridge Capital Buys Charter Communications, American Homes 4 Rent, Tesla Motors, Sells Owens-Cor Nov 14 2013 
Billionaires Active on PXD, THC, SNI Nov 10 2013 
Real-Time Rodeo and Round Up - Reduction Trades May 24 2013 
John Griffin's Top 5 Increases of the First Quarter May 24 2013 

More From Our Partners
Top 4 NYSE Stocks In The Hospitals Industry With The Highest Revenue Aug 21 2014 - BENZINGA

More From Other Websites
Tenet Healthcare Reaches 52-Week High on Q2 Earnings Beat Aug 19 2014
How Rick Perry Could Warm To Obamacare's Medicaid Expansion Aug 17 2014
Quantitative screens: relative strength scans Aug 14 2014
Corporate America's 'report cards' are strong Aug 11 2014
Red States Pressured To Expand Medicaid As Care Contrasts Emerge Aug 10 2014
TENET HEALTHCARE CORP Financials Aug 09 2014
Obamacare Patients Boost Tenet To Best Performance In CEO Memory Aug 05 2014
Tenet Healthcare Q2 Earnings Beat, Down Y/Y, Guides High Aug 05 2014
How Will Tenet Healthcare (THC) Stock Be Helped By This Analyst Action? Aug 05 2014
[video] Tenet CEO on compassionate use Aug 05 2014
[video] Time for Tenet's quarterly checkup Aug 05 2014
Tenet posts smaller 2Q loss Aug 04 2014
Tenet posts smaller 2Q loss Aug 04 2014
Updates, advisories and surprises Aug 04 2014
[$$] Tenet Healthcare's Loss Narrows Aug 04 2014
Tenet Climbs On Mixed Q2, Guidance Aug 04 2014
Why Tenet Healthcare (THC) Stock Is Gaining In After-Hours Trading Today Aug 04 2014
Tenet Healthcare raises outlook as patient admissions rise Aug 04 2014
Tenet Health posts narrower loss as sales surge Aug 04 2014
Tenet Reports Adjusted EBITDA of $460 Million for the Quarter Ended June 30, 2014 Aug 04 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide